Kayentis

News

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.

News

The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.